Life Sciences Archive » August, 2011

Life Sciences - August, 2011

185 articles

• Baxter Sues Teva Over Propofol Indemnity Pact
• CareFusion Hits Hospira With Infusion System IP Suit
• FDA Urged To Ban J&J, Allergan Breast Implants
• Merck, Others Can't Dodge Jury's Chromium Verdict
• 2 Classen Patents Pass Bilski Test: Fed. Circ.
• Urology Group Settles Pa.'s Monopoly Claims
• 9th Circ. Sanctions Alioto Firm For Southwest Merger Row
• Merck Sues Ky. AG For Using Private Firm In Vioxx Suit
• Medicare Revision Doesn't Bar Contract Suit: Fed. Circ.
• Tainted Avastin Caused Eye Infections: FDA
• Acella Loses Bid To Nix False Ad Suit Over Vitamin Labels
• ACA Adaptation: Benefits And Coverage Summaries
• Merck Gets Bellwether Suit Slashed In Fosamax MDL
• Bankrupt Drug Tester Can Avoid Inova Lien: 8th Circ.
• Avanir Targets Wockhardt In Nuedexta Patent Blitz
• Ex-Pharma Holdings Execs Shell Out $2M To End Fraud Suit
• Drug Co. Seeks Quick Win On False Ad Claims In IP Suit
• Pfizer Settles Lipitor Patent Suit Against Dr. Reddy's
• Bristol-Myers Hit With IP Suit Over Data Encryption
• Shire Patent Suit Over Generic Intuniv Survives
• Mylan Loses Bid To Dismiss MS Drug Patent Suit
• Cedars-Sinai Can't Shake Doc's $4.7M Retaliation Award
• 3M Stakes New Forum In BacLite Blackmail Suit
• 11th Circ. Vacates Sanctions Against US In Shaygan Case
• Group Seeks Faster Label Updates For Generics Makers
• Allergan Sues Sandoz Over Lumigan Patents
• Private Equity Firm Offers $30M For Point Blank Assets
• CVS Asks High Court To Put W.Va. Drug Suit In Fed. Court
• Doc Says Tampa Firm Cut Him Out Of Genzyme Qui Tam
• Mylan's Generic Oracea Infringes Galderma IP: Judge
• Amgen Can't Dodge Kickback Claims In Aranesp Suit
• Merck's $32M Damages Nixed In Vioxx Wrongful Death Suit
• Shuttered Drug Co. Recalls Surgical Antiseptics
• UBS Didn't Earn $7.8M Transaction Fee: Stem Cell Co.
• Alcon Sues Apotex Over Generic Allergy Spray
• 2nd Circ. Nixes Wells Fargo Credit Agreement Row
• Teva Nixes Suit Against Apotex Over Parkinson's Drug
• Hansen Medical Securities Fraud Action Nixed
• Hologic Workers Win Initial Cert. In Overtime Action
• Medtronic Insulin Pumps Open To Cyberattack: Hacker
• Fed. Circ. Upholds Unigene Win Over Fortical Patents
• Michael Best Adds Polsinelli IP Attys In Chicago
• Kirkland Reps Baxter International In $380M Baxa Buy
• Concrete Co. Cops To Price-Fixing Scheme
• Mass. Asks To Join Healthpoint Fraud Suit Over Xenaderm
• US Sues To Freeze Assets In Weight Loss Clinic Fraud Case
• A Hindsight-Averse Application Of Lead Compound Case Law
• Sanofi Unit Snaps Up Indian OTC Business For $109M
• Par, UCB Pharma Settle Keppra Patent Fight
• High Doses Of Celexa May Cause Heart Disorder: FDA
• 5th Circ. Gives Stryker Knee Implant Action New Life
• Investor Hits Advanced Cell With $12M Stock Fraud Suit
• CAE Adds Medical Simulator Co. METI For $130M
• Orrick, Arent Rep Par Pharma In $410M Anchen Buy
• Judge Strips Ethypharm's Antitrust Suit Over TriCor IP
• Contractor Settles Civil Suit Over Fake Drug Test Claims
• GSK Drug Reps Ask High Court To Review OT Exemption
• Fed. Circ. Won't Revive Novartis Hemophilia Drug IP Suit
• The Product Malfunction Theory Lives On
• Novartis Settles Famvir Patent Dispute
• NBTY Unit Faces Class Action Over Joint Repair Claims
• Beckman Must Boost Lab Device Quality Practices: FDA
• Lessons From Stanford
• Attys See Writing On Wall In Authors' Copyright Suits
• Allergan Triumphs In Suits Over Generic Combigan
• Ex-Head Of Drug Testing Co. Cops To Billing Fraud
• Blankfein Retains Steptoe White Collar Veteran
• Walgreen Nabs Ex-United Air Top Atty
• Cravath Reps Aptuit In $410M Deal With Catalent
• CVS Agrees To Pay $2M Over Misleading Pricing Ads
• Masimo Hit With Oximetry Device IP Suit
• Universal May Have To Open Books For 'Smokey' Producer
• FTC Loses Lundbeck Baby Meds Fight Before 8th Circ.
• Cadence Sues Exela, Paddock To Block Generic Ofirmev
• Novartis, Apotex Resolve Suit Over Myfortic Patents
• Schering Says Judge Missed Key Facts In Sales Rep OT Suit
• Calif. Court Allows Class Pursuit In Listerine Ad Suit
• Class Status Sought In Express Scripts-Medco Deal Suit
• Blank Rome Scores IP Pro From Vorys
• Overhauling The 510(k) Process
• Smith & Nephew Hit With Knee Implant Patent Suit
• Ex-Lab Owner Admits To Selling Unapproved Stem Cells
• KVK Accuses Sunrise Of Stealing Employees, Trade Secrets
• Sandoz Wants Novo's Prandin Patent Ruled Invalid Again
• Allergan Sues Again To Block Generic Latisse
• Forest Labs Defeats Icahn In Proxy Fight
• Laying Claim To DNA
• Endo Strikes Mylan With Suit Over Generic Frova
• Panel Backs Most Allegra Ad Claims
• Pfizer Sues To Block Generic Lipitor
• P&G Denture Cream Suits To Stay Put In MDL
• Darvocet, Darvon Heart Risk Suits Consolidated
• Baxter Says Fresenius Owes $20M Over Dialysis Patent
• Staples Faces IP Suit Over Data Security Patent
• Medicis, Nycomed Settle Vanos Patent Dispute
• Abbott Targets Teva Over Latest Simcor ANDA
• Personalized Medicine, Patents And The Supreme Court
• Abbott Hit With 2 Suits Over Depakote Birth Defects
• Indirect Purchasers Certified In Wellbutrin Antitrust Suit
• Judge Boots Investor Class Action Over Feraheme Risks
• Pfizer Sues Merck, Schering Unit Over Lipitor Look-Alike
• FDA Unveils New Standards For Premarket Device Studies
• Investors Target BioMimetic Over Bone Graft Statements
• Pfizer's Viagra Patent Survives Teva Challenge
• Sanofi Says Sales Rep OT Suit Exploits FLSA Loophole
• Ex-FrontPoint Trader Cops To Receiving Insider Tips
• Fed. Circ. Denies Eon's Fee Bid In Skelaxin IP Case
• Body Science Aims To Ax Winston & Strawn From IP Case
• Feds Pan Ex-Point Blank CEO's Retrial Bid In $189M Scam
• Stryker Unit Dodges Zimmer's Sanctions Bid
• Ex-Nasdaq Exec Gets 3 1/2 Years For Insider Trades
• AstraZeneca Settles Idaho's AWP Suit For $2.5M
• CORRECTED: Ex-Nasdaq Exec Apologizes For Insider Trading
• GSK Wins False Patent Marking Suit Over Citrucel
• SEC Demands Info On Deere's Overseas Activities
• Avanir Sues Par, Actavis To Block Generic Nuedexta
• Inside Sorrell V. IMS Health
• Legal Implications Of New Cancer Causation Theories
• Ex-FrontPoint Trader Ends $30M SEC Insider Trading Suit
• Bayer, Lilly False Ad Row Over Pet Meds To Stay In NY
• Elan Beats Investor Fraud Claims Over Drug Prospects
• Vioxx Judge Reallocates $315M Counsel Award
• Credit Downgrade May Yield Ready-Made Fraud Defense
• Lilly, Hospira Settle Gemzar Patent Fight
• S&N Relator Seeks Sales Docs For Non-US Goods
• Pfizer Can't Shake Investor Suit Over Off-Label Marketing
• EU Patent Decision Admissible In Yaz Row, Bayer Says
• J&J Cuts Deal With US Over Risperdal Marketing Fraud
• Former Point Blank CEO To Cop To Tax Charges: Atty
• Cooley Snags 3 Life Sciences Partners From Seed IP
• Caliper, Carestream Settle Animal Imaging IP Row
• Wyeth, Sandoz Lay Down Swords In Effexor Patent Row
• Most Claims Stand In Securities Suit Over Vioxx Risks
• Zimmer Knee Implant Actions Merged Into MDL
• Celanese Unit Must Face Fiber Price-Fixing Suit
• Abbott Fights $3.5M Verdict In GSK Suit Over Norvir
• Forest Decision Does Little To Remove Exclusion Threat
• Canadian Class Certified In Suit Over Wyeth's Premarin
• US Probes Merck's Marketing Of 3 Drugs
• Teva Sued Over Generic HIV Drug
• FTC Says NY Pharmacy Choice Bill Could Curb Competition
• Pozen Wins Injunction On Generic Treximet
• Ex-Schering Sales Reps Prevail In FLSA Suit
• Hogan Lovells Snags Ex-Medtronic Atty With FDA Chops
• 1st Circ. Tosses Boston Scientific Securities Fraud Action
• Brigham And Women's Hospital Says It Lost Patient Info
• US Ends Bid To Oust Forest Labs CEO Solomon
• Canada Links Merck Drugs To Male Breast Cancer
• Ex-Orioles Player Settles Insider Trading Suit For $2.5M
• Ferring, Aventis Reach $20M Deal In DDAVP Antitrust Suit
• Illumina Asks Fed. Circ. To Revive Affymetrix IP Suit
• AstraZeneca Targets Hetero Over Nexium ANDA
• Surviving The 'Magic Microscope' Test
• Forest Labs Told To Turn Over Docs On CEO To Icahn
• Prescription Confidentiality Law And The Privacy Debate
• Baker Donelson Adds Ex-Bayer CropScience Patent Head
• High-Dose Diflucan May Cause Birth Defects: FDA
• Watchdog Attacks FDA Over Expert Conflicts Policy
• 8th Circ. Revives KV Antifungal Cream Trade Secrets Row
• 10th Circ. Revives Prozac Murder-Suicide Suit
• KemPharm Exec Can't Dodge Shire's Contract Claims
• Omnicom Courts Big Pharma With Synergy Deal
• WebMD Accused Of Hiding Ad Woes Before Stock Plunge
• Heightened Standard For The Entire Market Value Rule?
• Detecting Waste And Abuse In Health Care Spending
• Chinese Reverse Merger Co. Hyped 'Worthless' Stock: Suit
• Takeda Accused Of Hiding Diabetes Drug's Cancer Link
• Judge Trims Boehringer Sales Reps' OT Class Action
• 8th Circ. Denies 3rd Look At Catheter Antitrust Suit
• J&J Unit Seeks To Nix Listerine False Marketing MDL
• US Oncology Debtholders Seek $40M From McKesson Tie-Up
• Feds Fail To Keep FCA Docs Sealed In Omnicare Case
• Immunosyn Execs Hit With $20M Insider Trading Suit
• Fed. Circ. Sides With GSK, Others In Argatroban IP Row
• Gilead Tries To Nix Whistleblower's Retaliation Suit
• Cantel Expands GI Capabilities With $100M Byrne Deal
• ATS Corporate Liability After Kiobel
• FMC To Shell Out $2.1B For Dialysis Cos.
• Pfizer Unit Wants $65M More For Asbestos Ch. 11
• Mass. Sues J&J Unit Over Risperdal Off-Label Marketing
• Proskauer Rose Sued For $140M Over Flawed Tax Advice
• Pharmacies Fight $29B Express Scripts, Medco Deal
• Insurers Must Cover Birth Control At No Cost: HHS
• Is The Medical Device Review System Flawed?
• Bringing Consistency Back To Patent Litigation